Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Health Canada Clears Zargis Medical’s Cardioscan

Zargis Medical, a subsidiary of Speedus, has reported that Health Canada, the Canadian equivalent of the FDA, has cleared its Cardioscan device for sale in Canada. Cardioscan is connected wirelessly to a Bluetooth-enabled electronic stethoscope and is designed to help physicians analyze cardiac sounds for the identification and classification of suspected heart murmurs.

The company claims that with 62,000 physicians treating a population of nearly 34 million people, Canada represents a significant market. Cardioscan’s optional telemedicine capabilities are well suited for the Canadian healthcare system, which has embraced telemedicine as a core initiative.

The introduction of Cardioscan heart sound analysis software into the market will provide benefits during face-to-face patient encounters and allow healthcare providers to extend the use of auscultation (listening with a stethoscope) to situations and environments where face-to-face encounters are not always feasible.

This clearance allows the company to begin marketing Cardioscan and the accompanying stethoscope in Canada.

John Kallassy, CEO of Zargis, said: “We’ve been seeing increasing interest among the Canadian medical community in Cardioscan and its telemedicine functionality, which is predictable given Canada’s geography and the nature of its population distribution.”